-
Synthesis of 2-cyclopropyl-3-(5-aryl-1-pyrazol-3-yl)-1,8-naphthyridine
-
Synthesis and biological evaluation of new 1-(4,6-dimethylpyrimidin-2-yl)-1′-aryl/heteroaryl- 3,3′-dimethyl-(4,5′-bipyrazol)-5-ols as antimicrobial agents
-
Synthesis and biological evaluation of new 1-(4,6-dimethylpyrimidin-2-yl)-1′-aryl/heteroaryl- 3,3′-dimethyl-(4,5′-bipyrazol)-5-ols as antimicrobial agents
-
An expeditious green route toward 2-aryl-4-phenyl-1-imidazoles
-
Structural comparison of the influenza A H5N1 hemagglutinin protein models across the 2001–2024 strains reveals cross-species similarity in the 2024 avian, human, and mammalian variants
-
Structural comparison of the influenza A H5N1 hemagglutinin protein models across the 2001–2024 strains reveals cross-species similarity in the 2024 avian, human, and mammalian variants
-
Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents
-
Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3)-quinazolinone derivatives
-
Design, synthesis, and biological evaluation of FXR/ASK1 dual-target modulators
-
Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase
-
Erratum to: Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase
-
Synthesis and biological evaluation of benzimidazole-linked 1,2,3-triazole congeners as agents
-
Pathway analysis by proteomics and molecular docking studies of a bioactive fraction, MBF1, from Saunders on the breast cancer MCF-7 cells
-
Pathway analysis by proteomics and molecular docking studies of a bioactive fraction, MBF1, from Saunders on the breast cancer MCF-7 cells
-
Synthesis of delta-1(9)-octalinols and their analogues
-
Chiral cyclopropenimine-catalyzed enantioselective Michael reactions of phenol and benzofuran-derived α,β-unsaturated pyrazolamides with benzophenone-imine of glycine esters
-
Network-based drug repositioning approach for tuberculosis
-
Network-based drug repositioning approach for tuberculosis
-
Nutraceutical powerhouses: leveraging α-amylase inhibitors for metabolic disease prevention
-
Nutraceutical powerhouses: leveraging α-amylase inhibitors for metabolic disease prevention
-
Exploring the potential cross-reactivity of allergenic proteins from using in-silico approaches
-
Identification of potent PDIA3 small molecule agonists via structure- and ligand-based drug discovery: a targeted approach to mitigate ER stress associated protein misfolding
-
Antimicrobial potential and global comparative proteomics of venom proteins from ants (), Wasp (), and honey bee ()
-
Structure-guided screening of bioactive phytoconstituents as prospective inhibitors of SARS-CoV-2 M
